#Cidara_Therapeutics
Investigation Regarding Fair Pricing for Cidara Therapeutics Shareholders by Ademi Firm#USA#Milwaukee#Merck#Ademi_Firm#Cidara_Therapeutics
Investigation Regarding Fair Pricing for Cidara Therapeutics Shareholders by Ademi Firm
The Ademi Firm is probing Cidara Therapeutics for possible fiduciary breaches regarding a recent deal with Merck that could impact shareholders.
third-news.com
November 14, 2025 at 3:18 PM